Dengue Vaccine Candidate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dengue vaccine candidate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dengue Vaccine Candidate Today - Breaking & Trending Today

Takeda's Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Through 4.5 Years in Pivotal Clinical Tria

Takeda today announced that its dengue vaccine candidate, TAK-003, prevented 84% of hospitalized dengue cases and 61% of symptomatic cases, with no important safety risks identified, in the overall population including both seropositive and seronegative individuals through four and a half years (54 months) after vaccination in the pivotal Phase 3 Tetravalent Immunization ....

United States , Gary Dubin , Serina Fischer , European Union , World Health Organisation , Dengue Efficacy Study , Northern European Conference , Travel Medicine , Eng Eong Ooi , General Manager , Latin America , Global Vaccine Business Unit , Dengue Vaccine Candidate ,